Kotak Healthcare Fund - Direct Plan - Growth Option
Kotak Mahindra Asset Management Company Limited · Direct Plan · Growth
Fund overview
0.50% on or before 30D, Nil after 30D
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,192 | +192 |
| 3 Years | ₹1,000 | ₹1,692 | +692 |
| 5 Years | ₹1,000 | ₹2,402 | +1,402 |
Calculated using the fund's annualised return since inception (19.2% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
35 securitiesTop 10 holdings make up 49.7% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals & Biotechnology | Large Cap | 13.21% |
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 9.35% |
| Molbio Diagnostics Ltd | Healthcare Equipment & Supplies | Small Cap | 5.08% |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Large Cap | 4.65% |
| AMI Organics Ltd | Pharmaceuticals & Biotechnology | Small Cap | 4.17% |
| Max Healthcare Institute Ltd | Healthcare Services | Mid Cap | 3.61% |
| Cipla Ltd | Pharmaceuticals & Biotechnology | Large Cap | 3.26% |
| Park Medi World Ltd | Healthcare Services | Small Cap | 3.17% |
| Gland Pharma Ltd | Pharmaceuticals & Biotechnology | Small Cap | 3.16% |
| Yatharth Hospital & Trauma Care Services Ltd | Healthcare Services | Small Cap | 3.12% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹825 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹814 Cr
Exit load, stamp duty & tax
11-Dec-23
0.50% on or before 30D, Nil after 30D
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | -- |
| Beta | -- |
| Sharpe Ratio | -- |
| Sortino Ratio | -- |
| Treynor Ratio | -- |
| Jensen's Alpha | -- |
| Information Ratio | -- |
| R-Squared | -- |
| Max Drawdown | -- |
| Upside Capture | -- |
| Downside Capture | -- |
Fund management
Scheme Details
Investment objective
The Investment Objective Of The Scheme Is To Seek To Generate Long Term Capital Appreciation Throughinvesting In Equity And Equity Related Securities Of Companies Benefitting Directly Or Indirectly Pharma, Healthcare, And Allied Sectors.
Fund house
Kotak Mahindra Asset Management Company Limited
Frequently asked questions
What is the NAV of Kotak Healthcare Fund - Direct Plan - Growth Option?
The NAV of Kotak Healthcare Fund - Direct Plan - Growth Option is ₹16.52 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by Kotak Healthcare Fund - Direct Plan - Growth Option?
The expense ratio charged by Kotak Healthcare Fund - Direct Plan - Growth Option is 1.04%.
What is the Min. SIP of Kotak Healthcare Fund - Direct Plan - Growth Option?
The minimum SIP investment in Kotak Healthcare Fund - Direct Plan - Growth Option is ₹100 per month.
What is the Min. Lumpsum of Kotak Healthcare Fund - Direct Plan - Growth Option?
The minimum lumpsum investment in Kotak Healthcare Fund - Direct Plan - Growth Option is ₹100.
What is the Exit Load of Kotak Healthcare Fund - Direct Plan - Growth Option?
The exit load for Kotak Healthcare Fund - Direct Plan - Growth Option is: 0.50% on or before 30D, Nil after 30D
.svg){kind=small}